Global News also reported that under the pricing structure of the pan-Canadian Pharmaceutical Alliance, when two generic medications enter the market they are at least 50 per cent cheaper than the brand name, though companies can price them lower
Gastroparesis is a chronic medical condition characterized by delayed gastric emptying in the absence of mechanical obstruction
Weight loss is fastest in the first few months, then slows as your body settles at a new set point thats metabolic adaptation, not the drug quitting, and most plateaus are temporary
Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease
Both compounds share the same mild gastrointestinal family of effects, and a slow, staggered ramp keeps them manageable
The incidence of diabetes is on the rise with 11.3 percent of the US population (37.3 million or roughly one in ten Americans) currently having the condition